Randomized, double-blind, placebo-controlled, phase II trial of gabapentin enacarbil for migraine prophylaxis

Cephalalgia

Volumn 33, Issue 2, 2013, Pages 101-111

  Silberstein, Stephen ^a   Goode Sellers, Stacey ^b   Twomey, Colleen ^b   Saiers, Jane ^c   Ascher, John ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b GLAXOSMITHKLINE   (United States)

^c WriteMedicine Inc   (United States)

Author keywords

Clinical trials; headache; migraine; randomized controlled

Indexed keywords

GABAPENTIN ENACARBIL; PLACEBO;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA; PHASE 2 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE;

ADULT; ANTICONVULSANTS; CARBAMATES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIGRAINE DISORDERS; PAIN MEASUREMENT; PLACEBO EFFECT; TREATMENT OUTCOME;

EID: 84871596041     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102412466968     Document Type: Article

References (23)

1. Rapoport AM. Acute and prophylactic treatments for migraine: Present and future. Neurol Sci. 2008 ; 29 (Suppl 1). S110 - S122
2. Mulleners WM, Chronicle EP. Anticonvulsants in migraine prophylaxis: A Cochrane review. Cephalalgia. 2008 ; 28: 585-597 (Pubitemid 351614940)
3. Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine: Report of an EFNS task force. Eur J Neurol. 2006 ; 13: 560-572 (Pubitemid 43873628)
4. Silberstein SD. Practice parameter: Evidence-based guidelines for migraine headache. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000 ; 55: 754-762
5. Stark RJ, Stark CD. Migraine prophylaxis. MJA. 2008 ; 189: 283-288
6. Cutrer RM, Limmroth V, Moskowitz MA. Possible mechanisms of valproate in migraine prophylaxis. Cephalalgia. 1997 ; 17: 93-100 (Pubitemid 27166262)
7. Rogawski MA. Common pathophysiologic mechanisms in migraine and epilepsy. Arch Neurol. 2008 ; 65: 709-714 (Pubitemid 351831448)
8. Gilron I. Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: Current evidence and future directions. Curr Opin Anaesthesiol. 2007 ; 20: 456-472 (Pubitemid 47415136)
9. Tzellos TG, Toulis KA, Goulis DG, et al. Gabapentin and pregabalin in the treatment of fibromyalgia: A systematic review and a meta-analysis. J Clin Pharm Ther. 2010 ; 35: 639-656
10. Bar Ad V. Gabapentin for the treatment of cancer-related pain syndromes. Rev Recent Clin Trials. 2010 ; 5: 174-178
11. Straube S, Derry S, Moore RA, et al. Single-dose oral gabapentin for established acute postoperative pain in adults. Cochrane Database Syst Rev 2010; CD008183.
12. Jimenez-Hernandez MD, Torrecillas Narvaez MD, Friera Acebai G. Effectiveness and safety of gabapentin in the preventive treatment of migraine. Rev Neurol. 2002 ; 35: 603-606
13. Vukovic V, Lovrencic-Huzjan A, Bosnar-Puretic M, et al. The efficacy of gabapentin in migraine prophylaxis: An observational open-label study. Acta Clin Croat. 2009 ; 48: 145-151
14. Di Trapani G, Mei D, Marra C, et al. Gabapentin in the prophylaxis of migraine: A double-blind randomized placebo-controlled study. Clin Ter. 2000 ; 151: 145-148 (Pubitemid 30482218)
15. Mathew NT, Rapoport A, Saper J, et al. Efficacy of gabapentin in migraine prophylaxis. Headache. 2001 ; 41: 119-128 (Pubitemid 32209899)
16. Vikelis M, Rapoport AM. Role of antiepileptic drugs as preventive agents for migraine. CNS Drugs. 2010 ; 24: 21-33
17. Cundy KC, Sastry S, Luo W, et al. Clinical pharmacokinetics of XP13512, a novel transported prodrug of gabapentin. J Clin Pharmacol. 2008 ; 48: 1378-1388
18. International Classification of Headache Disorders (ICHD-II), 2nd edition. Cephalalgia. 2004 ; 24 (Suppl 1). 1-160
19. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika. 1988 ; 75: 800-802
20. Macedo A, Banos JE, Farre M. Placebo response in the prophylaxis of migraine. Eur J Pain. 2008 ; 12: 68-75
21. Lal R, Sukbuntherng J, Luo W, et al. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: A randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers. Clin Ther. 2009 ; 31: 1776-1786
22. Merlino G, Serafini A, Young JJ, et al. Gabapentin enacarbil, a gabapentin prodrug for the treatment of the neurological symptoms associated with disorders such as restless legs syndrome. Curr Opin Investig Drugs. 2009 ; 10: 91-102
23. Irving G, Jensen M, Cramer M, et al. Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: Results of a double-blind, randomized, placebo-controlled clinical trial. Clin J Pain. 2009 ; 25: 185-192